Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Characteristics of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Taking Injectable and Oral Disease Modifying Treatments (Dmt) In Europe (Eu).
Relapsing Remitting Multiple Sclerosis Patients Initiated on Oral Dmf Report A Better Quality of Life Compared to Patients on Platform Therapies As Measured By Eq-5d.
Cognitive and psychiatric comorbidities in neuromyelitis optica.
Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation.
Correction: Search for Cellular Stress Biomarkers in Lymphocytes from Patients with Multiple Sclerosis: A Pilot Study.
Effectiveness of psychologically focused group interventions for Multiple Sclerosis: A review of the experimental literature.
Effect of light finger touch in balance control of individuals with multiple sclerosis.
An ex-vivo multiple sclerosis model of inflammatory demyelination using hyperbranched polymer.
Cause and prevention of demyelination in a model multiple sclerosis lesion.
Panic disorder as presenting symptoms of multiple sclerosis.
Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis.
Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis.
Mental Health in Multiple Sclerosis Patients without Limitation of Physical Function: The Role of Physical Activity.
Ipilimumab in patients with melanoma and autoimmune disease.
[Immunotherapies for multiple sclerosis : Review and update.]
Features of Human CD3+CD20+ T Cells.
Frequent Infection of Neurons by SV40 Virus in SIV-Infected Macaque Monkeys with Progressive Multifocal Leukoencephalopathy and Meningoencephalitis.
IL-27 Induces Th17 Differentiation in the Absence of STAT1 Signaling.
Stratified mixture modeling for segmentation of white-matter lesions in brain MR images.
Increased contrast enhancing lesion activity in relapsing-remitting multiple sclerosis migraine patients.
Curbing Inflammation in Multiple Sclerosis and Endometriosis: Should Mast Cells Be Targeted?
Estimating a minimal clinically important difference for the EuroQol 5-dimension health status index in persons with multiple sclerosis.
Deep grey matter involvement in multiple sclerosis: key player or bystander?
Different Mechanisms Regulate Expression of Zebrafish Myelin P0 in Myelinating Oligodendrocytes and its Induction Following Axonal Injury.
The New England Journal of Medicine publishes pivotal data demonstrating efficacy and safety of oral BG-12 (dimethyl fumarate) in multiple sclerosis.
Pages
« first
‹ previous
…
551
552
553
554
555
556
557
558
559
…
next ›
last »